by NYU Langone Health A rapid increase in “virtual” visits during the COVID-19 pandemic could transform the way physicians provide care in the United States going forward, according to a new study led by researchers from NYU Grossman School of Medicine. The findings, published online this week in the Journal of the American Informatics Association,...
by Danielle Hawkins, George Mason University Bruise detection and diagnosis is currently conducted by sight, under regular light, and bruises are often difficult to see on victims of violence depending on their skin color and the age of their injury. As a result, individuals with dark skin tones are at a significant disadvantage in having...
by Johns Hopkins University Bloomberg School of Public Health Older adults with depression may be at much higher risk of remaining depressed if they are experiencing persistent or worsening sleep problems, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health. The researchers, who published their findings online April 30 in...
By ELIZABETH COONEY Before Wednesday’s hopeful news about the experimental antiviral remdesivir broke, doctors treating patients hospitalized for Covid-19 were already hearing from a few families desperate to get the drug for their loved ones. Now they expect to hear more pleas in the days to come, even though the data are preliminary, results are...
To more quickly identify drug combinations, such as those that might treat COVID-19, researchers have come up with an artificial intelligence platform called IDentif.AI. Traditionally, when dangerous new bacterial and viral infections emerge, the response is to develop a treatment that combines several different drugs. However, this process is laborious and time-consuming, with drug combinations...
Philadelphia, April 29, 2020–Patients with untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma now have a new treatment option–a combination of the targeted agent ibrutinib with the immunologic agent rituximab. The U.S. Food and Drug Administration (FDA) has approved the combination based on data from E1912, a phase 3 trial developed and led by...
by American Geriatrics Society “Potentially inappropriate medications (PIMs)” are treatments that sometimes pose risks that outweigh their benefits, particularly for people who are 65 or older. About 20 to 60 percent of older adults take medicines that may be potentially inappropriate. That can increase the risk for being hospitalized, needing to visit the emergency department,...
by University of Liverpool University of Liverpool researchers have published new estimates of the global burden of hepatitis D, and are calling for more efforts to tackle the ‘forgotten’ virus. In a study published in the Journal of Hepatology, Professor Anna Maria Geretti and Dr. Alexander Stockdale, in collaboration with researchers from the World Health...
by Edith Cowan University The COVID-19 pandemic has significantly disrupted our experiences of, … ath and bereavement. Edith Cowan University Lecturer and Psychotherapist Karen Anderson has used key research and her own observations working on the frontline of counseling to explain the impact of this pandemic on the grief process, and how we can better...
by Helmholtz Association of German Research Centres For people with allergies, contact with pollen leads to symptoms such as sneezing, rhinitis and watery eyes. This may sound trivial, but is in fact a complex correlation of physiological processes. As these have not yet been fully understood, we do not know exactly yet how allergies develop...
